chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had an ear infection: Also, I had a sore throat if I slept wrong and the drip stuff occurred. I was tired in the mornings. I was tired at night, too. For the first five days of  the amoxicillin - had diarrhea; Loss of appetite but had more of an appetite back yesterday.  Diarrhea going on for five days - they put me on amoxicillin for the ear infection and that was maybe bothering my stomach.  My ear infection stuff is still going on presently - I am still getting sinus pressure headaches so I may need a re-check.  But I had nothing respiratory the whole time.
This case was reported by a consumer and described the occurrence of influenza in a 63-year-old male subject who was vaccinated with Influenza vaccine (manufacturer unspecified). A physician or other health care professional has not verified this report. On an unspecified date the subject received unspecified dose of Influenza vaccine. At an unspecified time after vaccination with Influenza vaccine, the subject experienced influenza and vaccination failure. This case was assessed as medically serious by GSK. At the time of reporting the outcome of the events was unspecified.
arms still a bit raised and itchy; random chills; hurt all over; horrible rash so itchy made her nuts; felt kind of crappy; allergy type of thing like hives on her arms; super bad headache like very bad; couldn't move neck; horrible chills; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (super bad headache like very bad), MUSCULOSKELETAL DISCOMFORT (couldn't move neck), CHILLS (horrible chills), RASH (horrible rash so itchy made her nuts) and FEELING ABNORMAL (felt kind of crappy) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Fibromyalgia and Breast implant palpable.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced HEADACHE (super bad headache like very bad), MUSCULOSKELETAL DISCOMFORT (couldn't move neck) and CHILLS (horrible chills). On 13-Mar-2021, the patient experienced RASH (horrible rash so itchy made her nuts), FEELING ABNORMAL (felt kind of crappy) and URTICARIA (allergy type of thing like hives on her arms). On 17-Mar-2021, the patient experienced PRURITUS (arms still a bit raised and itchy), CHILLS (random chills) and PAIN (hurt all over). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, HEADACHE (super bad headache like very bad), MUSCULOSKELETAL DISCOMFORT (couldn't move neck), CHILLS (horrible chills), RASH (horrible rash so itchy made her nuts), FEELING ABNORMAL (felt kind of crappy), URTICARIA (allergy type of thing like hives on her arms), PRURITUS (arms still a bit raised and itchy), CHILLS (random chills) and PAIN (hurt all over) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 62-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Jan2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 17Feb2021 at 08:00 as dose 2, single (Batch/Lot number: unknown), in left arm, on 29Sep2021 at 02:00 as dose 3 (booster), single (Lot number: 301358A), in left arm and on 27Apr2022 at 13:00 as dose 4 (booster), single (Lot number: FM9992) at the age of 62 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Allergies" (unspecified if ongoing), notes: Other medical history: Allergies. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional information: No other medication in 2weeks.No known allergies reported for the patient. Other medical history mentioned as Allergies. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This was the third Moderna shot I have received, a booster.  After each one I have had significant chills and muscle soreness, and some fever.  Same this time.  However, this time, I became somewhat hallucinogenic, and was unaware of my surroundings and of many of the things I said and did over a period of about six hours.  My family said I presented symptoms of a light stroke, and they were preparing to take me to the ER when I began to improve.   It was scary!!
Information has been received from a healthcare worker and refers to multiple unspecified patients of unknown ages and genders. There was no information about patients' concurrent conditions, medical history or concomitant medications. On multiple unknown dates, the patients were most likely vaccinated with doses of improperly stored M-M-R II (rHA) lot # M028130, expiration date of 03-JUN-2018 or lot # M049212, expiration date of 16-DEC-2018, (route of administration and anatomical location were not reported) for prophylaxis, which were stored in the range of 9.8  Celcius degrees for 1 hour. Previous temperature excursion was reported: 14.7 Celcius degrees for 3 hours. Concomitant therapies included sterile diluent (STERILE DILUENT). No adverse effects were reported. Digital data logger was involved. This is one of several reports from the same source.; Sender's Comments:  US-009507513-1709USA006502:
induration of @ least 10 cm; treated w/cool packs & DPH; last Td > 20 yrs ago;
Developed chest pain and was admitted for myocarditis on 25 May 2009. Admitted to medical center. Received call through call center reporting post-SPV associated myocarditis case. Contact information of patient was obtained, but after several attempts, has been unable to contact patient or his PCM. (Will continue to try and file follow up VAERS as more information becomes available).  7/10/09 Hospital outpatient records received 5/25/09 to 7/10/09. Assessment: Pericarditis. Patient presents for follow-up of inpatient admission for pericarditis. Sharp chest pain. Active meds include: ranitidine, ibuprofen.  Follow-up: No contact with patient. No new entries in DoD EMRs.
DTP given @ 12noon approx 8PM taken to Er w/uncontrollable crying w/onset about 30min before, rash & swelling @ inject site; t99r, pulse 200; ice pack to inject site, APAP;
Pt reports taking the first dose of VIVOTIF on 8/14/18 @ 1900, then began experiencing rash, tachycardia (HR 135), and tingling fingers on 08/16/18 at 1100. Denies taking any other new medication. He presented to local emergency room where he reports that Benedryl was administered. States that this relieved all symptoms.
vaccines were removed from the freezer on date of appointments to be used,; No adverse event; Dose administered after manufacturer date of expiry to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry to patient), PRODUCT STORAGE ERROR (vaccines were removed from the freezer on date of appointments to be used,) and NO ADVERSE EVENT (No adverse event) in an 18-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 022J21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Jun-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 02-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry to patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccines were removed from the freezer on date of appointments to be used,) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry to patient), PRODUCT STORAGE ERROR (vaccines were removed from the freezer on date of appointments to be used,) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry to patient) and PRODUCT STORAGE ERROR (vaccines were removed from the freezer on date of appointments to be used,).    No concomitant medications were reported. Total 200 doses and 20 vials were administered. The vials were initially stored in the refrigerator on 05-May-2022, 06-May-2022, 19-May-2022, 02-Jun-2022, 09-Jun-2022 and 23-Jun-2022. Reporter explained that vaccines were removed from the freezer on date of appointments to be used, and any unused portion was put in refrigerator. The vial did not undergo any temperature excursions. No treatment medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-619547 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-619547:
pt recv vax & devel inj site rxn characterized by redness & swelling w/pain radiating from site down the arm;pt has recv vax in the past;this is one of ten patients who exp above rxn p/vax;
Have lost a lot of hair; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP), Program ID: (RA). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 20Sep2022 as dose 3 (booster), single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Comirnaty (dose 1, single; lot number: unknown), administration date: 13Mar2021, for COVID-19 immunization, reaction: "Hair loss"; Comirnaty (dose 2, single; lot number: unknown), administration date: 16Apr2022, for COVID-19 immunization, reactions: "Inappropriate schedule of vaccine administered", "Hair loss". The following information was reported: ALOPECIA (non-serious), outcome "unknown", described as "Have lost a lot of hair". Therapeutic measures were taken as a result of alopecia. Additional information: The patient have lost a lot of hair due to getting the COVID-19 vaccine and booster. The patient's hair was great until he/she got the vaccine on 13Mar2023 and noticed his/her hair on the sink and then a lot of hair loss after the 16Apr2022 shot and the 20Sep2022 booster. The patient had bangs all his/her life and now has no bangs, the hair on top was so thin. It was devastating. The patient have before and after photos and loss of hair can be seen in them. The patient spent close to $3,000 on platelet-rich plasma (PRP) blood platelet treatments in Feb2023, and a topper costing $811.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300104044 same patient, drug, and event; different dose;US-PFIZER INC-202300219428 same patient and drug; different dose and event;
cut her hand during the process of removing the vial from the packaging; her hand during the process of removing the vial; Occupational exposure via skin contact with product; the glass broke at the bottom of the vial; This case was reported by a pharmacist via call center representative and described the occurrence of laceration of hand in a female patient who received Herpes zoster (Shingrix) (batch number 47D2Z, expiry date 24th April 2022) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, immediately after receiving Shingrix, the patient experienced laceration of hand, exposure via skin contact, occupational exposure via skin contact with product and pharmaceutical product complaint. On an unknown date, the outcome of the laceration of hand, exposure via skin contact, occupational exposure via skin contact with product and pharmaceutical product complaint were unknown.   It was unknown if the reporter considered the laceration of hand to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. The first eight doses and the tenth dose in the package were intact. When the patient removed the ninth antigen vial from the package, the glass broke at the bottom of the vial. The product was clearly not damaged due to shipping. There was no antigen seen inside or outside the vial. Two areas of the vial were chipped, and a hole was seen inside the vial. The patient cut her hand during the process of removing the vial from the packaging, which led to exposure via skin contact and occupational exposure via skin contact. The reporter consented to follow up. All information was not available.
Pt states that she had dose 1 of Moderna on 3/18. About a week later pt noticed her BP became elevated, she had a bad h/a, she also experienced dizziness, lightheadedness and some intermittent confusion.
This spontaneous report as received from a Nurse regarding a patient of unknown demographics. There was no information about concurrent condition and historical medication. On 04-SEP-2018, the patient was vaccinated with improperly stored PROQUAD lot # N020620, expiration date: 23-AUG-2019, dose 1 for prophylaxis. Concomitant therapies included sterile diluent. The vaccine had temperature excursion of -14 degree C to -10 degree C for 10 hours 15 minutes. Previous temperature excursion of -14 degree C to -10 degree C for 127 Hours and 45 Minutes. The call was due to the digital data logger. No adverse event was reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1810USA001739.
FLU-LIKE SYMPTOMS; SICK; FEVER; SORE THROAT; HEADACHE; BODY ACHES; This spontaneous report received from a consumer concerned a 42 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included felt sick, and covid-19. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. The batch number was not reported. On APR-2021, Laboratory data included: COVID-19 virus test negative (NR: not provided) Negative. On 09-APR-2021, the subject experienced body aches. On 09-APR-2021, the subject experienced headache. On 23-APR-2021, the subject experienced sore throat. On 24-APR-2021, the subject experienced flu-like symptoms. On 24-APR-2021, the subject experienced sick. On 24-APR-2021, the subject experienced fever. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 100.4 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, body aches, flu-like symptoms, sore throat, and fever, and the outcome of sick was not reported. This report was non serious.
He began feeling weakness, tingling, numbness in arms and legs. Weakness got worse until he visited the ER unable to support his own weight. He remained in the hospital about a month with paralysis, eventually regaining some movement of his arms and legs. Has been unable to support his own weight or walk without assistance ever since his release.
Developed trigger finger right thumb and transient AFIB. Never had any heart iriblem before. I felt it was post inflammatory.  reaction. Treated myself with oralInoroohen. . Afib resolved after one hour, trigger thumb improved after 3 hours.
Experiencing a buzzing feeling and twitchy in my feet and legs most noticeable when laying down. Also notice it now in my hands a bit. Some twitching in toes and fingers. Feel a bit jittery or trembly internally.  Abdominal pain on and off throughout the last week.  Slight dizziness at times.
Eyes became red and irritated, high level of fatigue began and shoulders, arms and upper back pain very noticeable.  By 6:30 PM exhaustion was evident and I slept for 3 hours.   I have never had any problems with any vaccination.  I am robust and in good health.  I would think a senior citizen in a frail condition would have had a scary and very unpleasant situation.
This spontaneous report as received from a other health professional refers to a 19 month old patient. On 21-JUL-2014 the patient was vaccinated with M-M-R II HSA (lot # H011885, expiration date: 25-JUN-2014) 0.5 ml, subcutaneously, which was expired. This is one of several reports received from the same source. Additional information has been requested.
headache; mall red raised bumps all over body, primarily on legs, spots inched and burned.; mall red raised bumps all over body, primarily on legs, spots inched and burned.; mall red raised bumps all over body, primarily on legs, spots inched and burned.; This is a spontaneous report from a contactable consumer. This 14-year-old male consumer (patient) reported for himself that: A 14-year-old male patient received first dose of bnt162b2 (BNT162B2, solution for injection, Lot number was not reported) dose 1 via an unspecified route of administration, administered in the right arm on 07Aug2021 at 13:00 (at the age of 14-year-old) as dose 1, single for COVID-19 immunisation at pharmacy or drug store. Medical history included headaches and covid-19. Concomitant medication(s) included ibuprofen (IBUPROFEN) taken for headache, start and stop date were not reported and paracetamol (TYLENOL) taken for headache, start and stop date were not reported. Patient reported past drug event as ibuprofen for known allergies as not until now ibuprofen. Patient was not received any other vaccine four weeks prior vaccination. On 18Aug2021 at 07:00 the patient experienced headache, shortly after developed small red raised bumps all over body, primarily on legs, spots inched and burned. Reported stated that took ibuprofen in the morning for a headache on 8/18. The same thing happened to mother. Since vaccination patient not tested for covid-19. The case assessed as non-serious by the reporter. Therapeutic measures were taken as a result of the events with with Otc Zyrtec. Waiting to see if paediatrician visit w. The clinical outcome of the events was reported as recovered with sequel on an unspecified date of 2021.   Follow-up attempts are completed. No further information is expected
When I went to the doctor at first they thought I had pneumonia. I was having difficulty swallowing. Anytime I swallow I felt like I was chocking. It has gotten better but not 100% resolved. I have ulcers in the back of my throat and my lungs swell up. I was prescribed an inhaler, nasal spray, a steroid, and albuterol. Those medications was not making me feel better. Then they discovered that I had ulcers in my throat. My right ear was clogged. The side of my throat was irritated. I had a build up of ear wax in my right ear. The doctor flushed the ear wax out. When I went to see an allergist, they tested me for allergies but I didn't have any. The allergists is the one who discovered the ulcers. I was prescribed new medications which was nasal spray called triamcinolone acetonide 55, steroids for 5 days, and nystatin oral suspension. If the oral rinse clears up whatever is going on with my throat, then the doctor said they won't have to put a scope down my throat. Sugar affects the ulcers so I changed my diet.
This spontaneous case, initially received from other non-health professional on 14-Nov-2018, concerning a female patient of unspecified age. On an unspecified date, the FLUCELVAX QIVc vaccine underwent first temperature excursion with Tmax 8.2 degree centigrade for 4 minutes. On 22-Oct-2018, vaccine underwent second temperature excursion with Tmax 9.8 degree centigrade for 23 minutes. On an unspecified date, two temperature excursions were identified after an audit. On 22-Oct-2018, the patient was inadvertently administered FLUCELVAX QIVc (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left deltoid, batch number: 252672 and expiry date: 30 Jun-2019) which underwent temperature excursion. The patient did not experience any adverse events after administration.
Fatigue, chills, muscle aches, mild headache. No treatment except bed rest.
received 2 full doses of Moderna after receiving Janssen/2nd dose of Moderna administered past 36 days; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received 2 full doses of Moderna after receiving Janssen/2nd dose of Moderna administered past 36 days) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Jansen on 22-Mar-2021. Past adverse reactions to the above products included No adverse event with Jansen.   On 25-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received 2 full doses of Moderna after receiving Janssen/2nd dose of Moderna administered past 36 days). On 25-Oct-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received 2 full doses of Moderna after receiving Janssen/2nd dose of Moderna administered past 36 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was reported.   This case was linked to MOD-2022-456253 (Patient Link).
Reoccurrence of fever blisters. Treated with antiviral and Abreva.
07/09/2023 arm soreness after receiving the vaccine. The pain progress over the course of a few days. I continue to have soreness in my left arm in the middle of shoulder. I continue to have shoulder soreness especially at night. I'm currently going to physical and massage therapy.
First dose received 07/2021. Second dose not yet received; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 36-year-old male patient who received HBV (Engerix B) for prophylaxis.   Previously administered products included Engerix-B (1st dose received on 1st July 2021).   On an unknown date, the patient received the 2nd dose of Engerix B. On an unknown date, unknown after receiving Engerix B, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable to this report. Till the time of reporting, the patient did not receive 2nd dose of Engerix-B, which led to incomplete course of vaccination. The reporter consent to follow up.